OssDsign ABOSTO:OSSD -2.87%58 Days Payable is 173.36 as of Mar. 2026, which is 39% above its 10-year median of 124.34. GuruFocus rates OSTO:OSSD with a GF Score™ of 58/100 and a GF Value™ of kr11.04 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, OssDsign AB ranks better than 86.42% on this metric.
The historical rank and industry rank for OssDsign AB's Days Payable or its related term are showing as below:
OSTO:OSSD'
s Days Payable Range Over the Past 10 Years
Min: 85.55 Med: 124.34 Max: 464.51
Current: 245.04
During the past 9 years, OssDsign AB's highest Days Payable was 464.51. The lowest was 85.55. And the median was 124.34.
OSTO:OSSD's Days Payable is ranked better than 86.42% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs OSTO:OSSD: 245.04
OssDsign AB's Days Payable
declined
from Mar. 2025 (292.45) to Mar. 2026 (173.36).
It may suggest that OssDsign ABaccelerated paying its suppliers.
OssDsign AB Days Payable Related Terms
OssDsign AB Days Payable Historical Data
* Premium members only.
The historical data trend for OssDsign AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:OSSD vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, OssDsign AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OssDsign AB Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OssDsign AB's Days Payable distribution charts can be found below:
* The bar in red indicates where OssDsign AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
OssDsign AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OssDsign AB (OSTO:OSSD) has a Days Payable of 173.36 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on OssDsign AB and its competitors. This is 39% above median its historical median of 124.34. Over the past decade, OssDsign AB's Days Payable has ranged from 85.55 to 464.51. According to the industry distribution chart, OssDsign AB ranks #108 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 13.6%.
Is OssDsign AB's Days Payable too high?
OssDsign AB's current Days Payable of 173.36 is 39% above median its 10-year median of 124.34. Over the past 10 years, this metric has ranged from a low of 85.55 to a high of 464.51. The Medical Devices & Instruments industry median Days Payable is 68.07. OssDsign AB's value of 173.36 is 154.7% above this industry median. Based on the distribution chart, OssDsign AB ranks #108 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, OssDsign AB has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does OssDsign AB's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, OssDsign AB ranks #108 out of 795 companies for Days Payable. This places OssDsign AB in the top 14% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.07. OssDsign AB's value of 173.36 is 154.7% above this benchmark. Historically, OssDsign AB's own Days Payable has ranged from 85.55 to 464.51 over the past decade. While the company's 10-year median is 124.34 vs. the industry median of 68.07, OssDsign AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OssDsign AB's current Days Payable of 173.36 is 154.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on OssDsign AB and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OssDsign AB's current Days Payable is 173.36, which is 39% above median its own 10-year median of 124.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OssDsign AB stock overvalued right now?
Based on GuruFocus' analysis, OssDsign AB (OSTO:OSSD) is currently considered Possible Value Trap. The stock's GF Value™ is kr11.04, compared to a current price of kr4.06 — trading 63.2% below its estimated fair value. The current Days Payable is 173.36, which is 39% above median its 10-year median of 124.34 and 154.7% above the Medical Devices & Instruments industry median of 68.07. OssDsign AB's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For OssDsign AB (OSTO:OSSD), the current Days Payable is 173.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OssDsign AB (OSTO:OSSD) Overvalued in 2026?
Based on GuruFocus' analysis, OssDsign AB stock appears to be undervalued.
The current stock price of kr4.06 is trading 63.2% below its estimated GF Value™ of kr11.04.
GuruFocus considers OssDsign AB to be Possible Value Trap.
Key valuation signals for OSTO:OSSD:
Days Payable: 173.36 (39% above median its 10-year median of 124.34)
GF Value™: kr11.04 vs. price of kr4.06 (63.2% below fair value)
Industry Position: 154.7% above the Medical Devices & Instruments median (#108 of 795)
No single metric tells the full story. See the OSTO:OSSD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OssDsign AB is a developer and international provider of next-generation orthobiologics products. The company's product OssDsign Catalyst is a bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries. Geographically the company generates revenue from the USA, Germany, Sweden and UK. The company generates the majority of its revenue from the USA region.
58GF Score
Get the complete analysis for OSTO:OSSD
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:OSSD has been successfully added to your 
